Literature DB >> 34114199

Comparison of two different surgical strategies for breast cancer patients treated with mastectomy plus sentinel lymph node biopsy.

Xing Zhang1, Qian Shen2, Yu-Jie Hu3.   

Abstract

Two separated incisions are generally adopted in breast cancer patients treated by mastectomy plus sentinel lymph node biopsy (SLNB). However, one-incision procedure is also applied in clinical practice. The outcomes of the two different surgical strategies remain unknown. This issue needs to be investigated. The medical records of breast cancer patients who underwent a mastectomy combined with an SLNB were reviewed retrospectively. Group A comprised patients who received a single incision for both the mastectomy and SLNB. Group B comprised patients who received a second incision for the SLNB. Demographics and outcomes were compared between the two groups. There were 280 female patients divided into Groups A (n = 130) and B (n = 150) included in this study. Preoperatively, the two groups were similar in demographics for age, tumor size, tumor location, body mass index, pathologic type, and cancer stage (P > 0.05). Group A showed shorter surgical times (129.5 ± 29.0 vs. 136.7 ± 21.9 min), less postoperative upper limb numbness (12.3% vs. 25.3%), and more harvested sentinel lymph nodes (3.2 ± 1.1 vs. 2.7 ± 1.0) than Group B (P < 0.05). There were no significant differences for intraoperative blood loss, total postoperative drainage amount, hospital stay, upper limb motility, upper limb pain, upper limb edema, number of metastatic sentinel lymph nodes, follow-up time, or recurrent cases (P > 0.05). The one-incision approach for a breast cancer mastectomy plus SLNB has several advantages over the two-incision approach, including a shorter surgical time, decreased upper limb numbness, and the harvesting of more sentinel lymph nodes. Further prospective randomized controlled clinical trials should be designed to verify the current findings.

Entities:  

Keywords:  Breast cancer; Incision; Mastectomy; Sentinel lymph node

Year:  2021        PMID: 34114199     DOI: 10.1007/s13304-021-01109-0

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  23 in total

1.  De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Authors:  G Curigliano; H J Burstein; E P Winer; M Gnant; P Dubsky; S Loibl; M Colleoni; M M Regan; M Piccart-Gebhart; H-J Senn; B Thürlimann
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

2.  Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Authors:  Gary H Lyman; Mark R Somerfield; Armando E Giuliano
Journal:  J Oncol Pract       Date:  2017-01-24       Impact factor: 3.840

Review 3.  Locoregional Management After Neoadjuvant Chemotherapy.

Authors:  Monica Morrow; Atif J Khan
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

4.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.

Authors:  Armando E Giuliano; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow; Karla Ballman
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

5.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

6.  Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer.

Authors:  Mara A Piltin; Tanya L Hoskin; Courtney N Day; John Davis; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2020-08-10       Impact factor: 5.344

7.  Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera.

Authors:  Thomas Papathemelis; Evi Jablonski; Anton Scharl; Tanja Hauzenberger; Michael Gerken; Monika Klinkhammer-Schalke; Matthias Hipp; Sophia Scharl
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

8.  Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.

Authors:  Yidong Zhou; Yan Li; Feng Mao; Jing Zhang; Qingli Zhu; Songjie Shen; Yan Lin; Xiaohui Zhang; He Liu; Mengsu Xiao; Yuxin Jiang; Qiang Sun
Journal:  BMC Cancer       Date:  2019-10-11       Impact factor: 4.430

9.  Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study.

Authors:  Long Yuan; Xiaowei Qi; Yi Zhang; Xinhua Yang; Fan Zhang; Linjun Fan; Li Chen; Kongyong Zhang; Ling Zhong; Yanling Li; Sijie Gan; Wenying Fu; Jun Jiang
Journal:  Cancer Biol Med       Date:  2018-11       Impact factor: 4.248

10.  Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.

Authors:  Weiqi Gao; Yufei Zeng; Xiaochun Fei; Xiaosong Chen; Kunwei Shen
Journal:  Breast Cancer Res Treat       Date:  2020-08-01       Impact factor: 4.872

View more
  1 in total

1.  Mean platelet volume may not decrease in patients with acute appendicitis.

Authors:  Cengiz Beyan; Esin Beyan
Journal:  Updates Surg       Date:  2021-02-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.